ATI Tech (ATYT) Pours Cold Water on AMD Hookup Rumor - The Globe and Mail

According to a report from The Globe and Mail, ATI Technologies Inc. (Nasdaq: ATYT) poured cold water on rumors AMD (NYSE: AMD) could be interested in buying the company. According to the report, ATI's spokesman, Chris Evenden, said, "There's been speculation like this for at least a decade and nothing has changed ... It was only last week there was a rumor that Intel (Nasdaq: INTC) was interested."

Today's ATYT/AMD rumors were sparked by comments in a research report from RBC Capital analyst Apjit Walia, who suggested the two could hookup.

Merger Markets analyst on CNBC Says Quest Diagnostics (DGX) Looking at Counter-Bid for Fisher Scientific (FSH)

Merger Markets analyst on CNBC said Quest Diagnostics Inc. (NYSE: DGX) is taking a strong interest in making a counter-bid for Fisher Scientific International Inc. (NYSE: FSH), which currently has a merger deal with Thermo Electron Corp. (NYSE: TMO).

Rumors Surround Orange 21 (ORNG) Following Recent Stake Disclosure

We've been hearing some chatter on Orange 21 Inc. (Nasdaq: ORNG) following recent news that Integrity Brands Fund has accumulated a 9.3% stake in the company, which was disclosed in a 13D filing with the SEC (05/22)

The Integrity Brands Fund, run by John Pound, is a focused equity fund that invests exclusively in Consumer brand and specialty retail companies; Design- and fashion-intensive companies, in particular. (Website: http://www.integrity-brands.com)

Current rumors suggest Ilia Lekach of Parlux Fragrances (PARL) could get involved with Orange 21 and the company could win a deal to manufacture the Paris Hilton line of sunglasses.

Parlux has a license agreements with Paris Hilton Entertainment, Inc. to develop, manufacture, and distribute cosmetics, watches and other time pieces, handbags, purses, wallets, and other small leather goods under the Paris Hilton name.

WR Hambrecht Positive on eLong (LONG), Including Possibility of EXPE Takeover

WR Hambrecht reiterates their Buy rating on eLong Inc. (Nasdaq: LONG) after reviewing China's e-travel results through Q1 in a report titled "Countdown to Takeout?"

The analyst said the company will continue to ride on leader Ctrip's (Nasdaq: CTRP) coattails. According to analyst Andy Van Vleck potential catalyst for LONG include "(1) healthy top line growth as China's seasonally weakest quarter is behind us; (2) improving earnings visibility as the market anticipates eLong breaking even in 2H:06; (3) further 'institutionalization' as funds search for cheaper exposure to China e-commerce; (4) speculation surrounding possible takeout, and the likely premium paid, as October's expiration of Expedia's (Nasdaq: EXPE) standstill approaches."